These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
3. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
4. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
5. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
6. Prokinetic therapy for gastroesophageal reflux disease. Robinson M Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432 [TBL] [Abstract][Full Text] [Related]
7. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
8. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
9. [Prokinetic drugs]. Hellström P Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341 [TBL] [Abstract][Full Text] [Related]
10. [Cisapride efficacy in gastroesophageal reflux in children]. Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715 [TBL] [Abstract][Full Text] [Related]
11. [Drug therapy of gastrointestinal motility disorders]. Jia B Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932 [No Abstract] [Full Text] [Related]
12. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
13. Domperidone, a new dopamine antagonist. Champion MC; Hartnett M; Yen M CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396 [TBL] [Abstract][Full Text] [Related]
14. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789 [TBL] [Abstract][Full Text] [Related]
15. [Gastroesophageal reflux in the newborn]. Urrusti-Sanz J Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609 [No Abstract] [Full Text] [Related]
16. Cisapride--more selective than metoclopramide. Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232 [No Abstract] [Full Text] [Related]
17. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
18. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010 [TBL] [Abstract][Full Text] [Related]